{"product_id":"the-ldn-book-volume-two-the-latest-research-on-how-low-dose-naltrexone-could-revolutionize-treatment-for-ptsd-pain-ibd-lyme-disease-dermatologic-paperback","title":"The Ldn Book, Volume Two: The Latest Research on How Low Dose Naltrexone Could Revolutionize Treatment for Ptsd, Pain, Ibd, Lyme Disease, Dermatologic - Paperback","description":"\u003cp\u003eby \u003cb\u003eLinda Elsegood\u003c\/b\u003e (Author)\u003c\/p\u003e\u003cp\u003e\u003cb\u003eA comprehensive examination of Low Dose Naltrexone--a little-known drug with big potential\u003cbr\u003e\u003c\/b\u003e\u003cbr\u003e\u003cb\u003e\"[LDN] raises hopes of reversing memory loss in old age.\"--\u003ci\u003ethe Guardian\u003c\/i\u003e\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e\u003c\/p\u003eA drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination. \u003cp\u003e\u003c\/p\u003eLDN, originally prescribed in higher doses as a treatment for opioid addiction, works by blocking opioid receptors, thereby stimulating the production of endorphins, mitigating the inflammatory process, and stabilizing the immune response. Prescribed off-label and administered in small daily doses, this generic drug has proven useful in treating many different ailments. \u003cp\u003e\u003c\/p\u003eExpanding on the information presented in \u003ci\u003eThe LDN Book, Volume 1\u003c\/i\u003e, which showcased LDN's efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue, \u003ci\u003eVolume 2\u003c\/i\u003e highlights the latest clinical trials, case studies, and research with explanations from a dozen medical professionals on how they are using LDN to help patients suffering from: \u003cp\u003e\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eChronic pain\u003c\/li\u003e\n\u003cli\u003eParkinson's disease\u003c\/li\u003e\n\u003cli\u003eDermatologic conditions\u003c\/li\u003e\n\u003cli\u003eTraumatic brain injury\u003c\/li\u003e\n\u003cli\u003eLyme disease and more \u003cp\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003ci\u003eThe LDN Book, Volume 2\u003c\/i\u003e is both a resource for practitioners, pharmacists, and patients, and a renewed call for further research on the healing potential of this generic drug.\u003ch3\u003eAuthor Biography\u003c\/h3\u003e\u003cp\u003e\u003cb\u003eLinda Elsegood\u003c\/b\u003e is the founder of the LDN Research Trust, which was set up in the UK as a Registered Charity in 2004, and is the editor of \u003ci\u003eThe LDN Book\u003c\/i\u003e. Diagnosed with MS in August of 2000, she started LDN therapy in December of 2003, and now has a better quality of life and hope for the future. Through the Trust, she has connected thousands of patients, doctors, and pharmacists around the world with information, articles, and patient stories about LDN.\u003c\/p\u003e\n        \u003cdiv\u003e\n\u003cstrong\u003eNumber of Pages:\u003c\/strong\u003e 288\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eDimensions:\u003c\/strong\u003e 0.8 x 8.8 x 5.9 IN\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eIllustrated:\u003c\/strong\u003e Yes\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003ePublication Date:\u003c\/strong\u003e September 24, 2020\u003c\/div\u003e\n            ","brand":"Books by splitShops","offers":[{"title":"Default Title","offer_id":51768864047392,"sku":"9781603589901","price":27.99,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0974\/9764\/5344\/files\/289ae6785de81b202e7929aee0a99bff.webp?v=1780339218","url":"https:\/\/ebocreations.com\/products\/the-ldn-book-volume-two-the-latest-research-on-how-low-dose-naltrexone-could-revolutionize-treatment-for-ptsd-pain-ibd-lyme-disease-dermatologic-paperback","provider":"The E-Book Oasis LLC","version":"1.0","type":"link"}